BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li X, Feng GS, Zheng CS, Zhuo CK, Liu X. Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: An experimental study. World J Gastroenterol 2003; 9(11): 2445-2449 [PMID: 14606073 DOI: 10.3748/wjg.v9.i11.2445]
URL: https://www.wjgnet.com/1948-5182/full/v9/i11/2445.htm
Number Citing Articles
1
Ju Hyun Shim, Joong‐Won Park, Ji Hoon Kim, Min An, Sun‐Young Kong, Byung‐Ho Nam, Joon‐Il Choi, Hyun Beom Kim, Woo Jin Lee, Chang‐Min Kim. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patientsCancer Science 2008; 99(10): 2037 doi: 10.1111/j.1349-7006.2008.00909.x
2
Daisaku Yamada, Shogo Kobayashi, Hirofumi Yamamoto, Yoshito Tomimaru, Takehiro Noda, Mamoru Uemura, Hiroshi Wada, Shigeru Marubashi, Hidetoshi Eguchi, Masahiro Tanemura, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic ResectionAnnals of Surgical Oncology 2012; 19(S3): 355 doi: 10.1245/s10434-011-1797-x
3
Hai-Lin Li, Wen-Bin Ji, Rui Zhao, Wei-Dong Duan, Yong-Wei Chen, Xian-Qiang Wang, Qiang Yu, Ying Luo, Jia-Hong Dong. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysisWorld Journal of Gastroenterology 2015; 21(12): 3599-3606 doi: 10.3748/wjg.v21.i12.3599
4
Katerina Malagari, Mary Pomoni, Alexis Kelekis, Anastasia Pomoni, Spyros Dourakis, Themis Spyridopoulos, Hippokratis Moschouris, Emmanouil Emmanouil, Spyros Rizos, Dimitrios Kelekis. Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular CarcinomaCardioVascular and Interventional Radiology 2010; 33(3): 541 doi: 10.1007/s00270-009-9750-0
5
Bingru Xie, David H. Wang, Stuart Jon Spechler. Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic ReviewDigestive Diseases and Sciences 2012; 57(5): 1122 doi: 10.1007/s10620-012-2136-1
6
Paolo Giunchedi, Marcello Maestri, Elisabetta Gavini, Paolo Dionigi, Giovanna Rassu. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1Expert Opinion on Drug Delivery 2013; 10(5): 679 doi: 10.1517/17425247.2013.770733
7
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsCritical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005
8
Mona El-Azab, Hailemichael Hishe, Yasser Moustafa, El-Sayed El-Awady. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing miceEuropean Journal of Pharmacology 2011; 652(1-3): 7 doi: 10.1016/j.ejphar.2010.11.008
9
Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean-Frederic Blanc, Lunan Yan, Jijin Yang, Ligong Lu, Won-Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi-Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian B. Walters, Christine Dela Cruz, Valerie Poulart, Jian-Hua Wang. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialHepatology 2014; 60(5): 1697 doi: 10.1002/hep.27290
10
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2005; : 91 doi: 10.1007/3-540-27194-5_8
11
Elisa Pinto, Filippo Pelizzaro, Romilda Cardin, Michele Battistel, Giorgio Palano, Federica Bertellini, Maria Piera Kitenge, Giulia Peserico, Fabio Farinati, Francesco Paolo Russo. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolizationDigestive and Liver Disease 2023;  doi: 10.1016/j.dld.2023.09.019
12
Tongqiang Li, Jiacheng Liu, Yingliang Wang, Chen Zhou, Qin Shi, Songjiang Huang, Chongtu Yang, Yang Chen, Yaowei Bai, Bin Xiong. Liver fibrosis promotes immunity escape but limits the size of liver tumor in a rat orthotopic transplantation modelScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02155-9
13
Katerina Malagari, Mary Pomoni, Themistoklis N. Spyridopoulos, Hippokratis Moschouris, Alexis Kelekis, Spyros Dourakis, Efthymia Alexopoulou, John Koskinas, Michalis Angelopoulos, John Kornezos, Anastasia Pomoni, Savvas Tandeles, Athanasios Marinis, Spyros Rizos, Dimitrios Kelekis. Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead™: Results of 237 Hepatocellular Carcinoma (HCC) PatientsCardioVascular and Interventional Radiology 2011; 34(4): 774 doi: 10.1007/s00270-010-0044-3
14
Bianca Rocco, Valentina Camelo, Valeria Feliciangeli, Carlo Catalano, Pierleone Lucatelli. Transarterial Chemoembolization (TACE)2023; : 1 doi: 10.1007/978-3-031-36261-3_1
15
Hye Ok Kim, Jae Seung Kim, Yong Moon Shin, Jin-Sook Ryu, Yung Sang Lee, Seung Gyu Lee. Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using 18F-FDG PET/CTJournal of Nuclear Medicine 2010; 51(12): 1849 doi: 10.2967/jnumed.110.079244
16
Jannis Kountouras, Christos Zavos, Dimitrios Chatzopoulos. Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignanciesJournal of Surgical Oncology 2005; 90(4): 249 doi: 10.1002/jso.20254
17
Eng Soon Teoh. Medicinal Orchids of Asia2016; : 131 doi: 10.1007/978-3-319-24274-3_8
18
Heng-Yi LIANG, Li-Gong LU, Bao-Shan HU, Yong LI, Pei-Jian SHAO. Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomasChinese Medical Journal 2013; 126(22): 4270 doi: 10.3760/cma.j.issn.0366-6999.20120478
19
David J. Pennisi, Takashi Mikawa. Normal patterning of the coronary capillary plexus is dependent on the correct transmural gradient of FGF expression in the myocardiumDevelopmental Biology 2005; 279(2): 378 doi: 10.1016/j.ydbio.2004.12.028
20
Junning Liu, Shu Yan, Guangnian Zhang, Linfeng Yang, Song Wei, Pengsheng Yi. A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinomaOncology Letters 2023; 26(6) doi: 10.3892/ol.2023.14094
21
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2010; : 421 doi: 10.1007/978-3-642-00150-5_28
22
Ko Oshita, Tsuyoshi Kobayashi, Yosuke Namba, Sotaro Fukuhara, Keiso Matsubara, Daisuke Takei, Ryosuke Nakano, Wataru Okamoto, Hiroshi Sakai, Naoki Tanimine, Takashi Nakahara, Shintaro Kuroda, Hiroyuki Tahara, Masahiro Ohira, Tomokazu Kawaoka, Kentaro Ide, Michio Imamura, Hiroshi Aikata, Hideki Ohdan. Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective studyBMJ Open 2023; 13(10): e073797 doi: 10.1136/bmjopen-2023-073797
23
Juan Wu, Jia Zeng, Huiwen Wang, Zhuoni Huo, Xunbo Hou, Dongfeng He. Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1244341
24
Liang Liu, Zheng‐Gang Ren, Yuan Shen, Xiao‐Dong Zhu, Wei Zhang, Wei Xiong, Yi Qin, Zhao‐You Tang. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transitionCancer Science 2010; 101(1): 120 doi: 10.1111/j.1349-7006.2009.01363.x
25
Yang Guo, Yue Zhang, Ning Jin, Rachel Klein, Jodi Nicolai, Robert J. Lewandowski, Robert K. Ryu, Reed A. Omary, Andrew C. Larson. Electroporation-Mediated Transcatheter Arterial Chemoembolization in the Rabbit VX2 Liver Tumor ModelInvestigative Radiology 2012; 47(2): 116 doi: 10.1097/RLI.0b013e31822e57cc
26
H. Cha, H. I. Yoon, I. J. Lee, W. S. Koom, K.-H. Han, J. Seong. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinomaJournal of Radiation Research 2013; 54(6): 1069 doi: 10.1093/jrr/rrt034
27
Chuang Jiang, Gong Cheng, Mingheng Liao, Jiwei Huang. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysisWorld Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02188-4
28
Wen W. Ma, Wells A. Messersmith. Interventional Oncology2008; : 222 doi: 10.1017/CBO9780511722226.020
29
Jean-François Dufour, Hanno Hoppe, Markus H. Heim, Beat Helbling, Olivier Maurhofer, Zsolt Szucs-Farkas, Ralph Kickuth, Markus Borner, Daniel Candinas, Bettina Saar. Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I StudyThe Oncologist 2010; 15(11): 1198 doi: 10.1634/theoncologist.2010-0180
30
Steven Lahti, Johannes M. Ludwig, Minzhi Xing, Lingyi Sun, Dexing Zeng, Hyun S. Kim, Yi-Hsien Hsieh. In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma—A pilot studyPLOS ONE 2017; 12(4): e0174539 doi: 10.1371/journal.pone.0174539
31
Richard H. Pin, Maura Reinblatt, William J. Bowers, Howard J. Federoff, Yuman Fong. Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinomaJournal of Gastrointestinal Surgery 2004; 8(7): 812 doi: 10.1016/j.gassur.2004.08.007
32
Li Li, Jia-Ling Huang, Qi-Cai Liu, Pei-Hong Wu, Ran-Yi Liu, Yi-Xin Zeng, Wen-Lin Huang. Endostatin gene therapy for liver cancer by a recombinant adenovirus deliveryWorld Journal of Gastroenterology 2004; 10(13): 1867-1871 doi: 10.3748/wjg.v10.i13.1867
33
Adriana Sergio, Chiara Cristofori, Romilda Cardin, Giorgio Pivetta, Roberto Ragazzi, Anna Baldan, Lisa Girardi, Umberto Cillo, Patrizia Burra, Anna Giacomin, Fabio Farinati. Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and InvasivenessThe American Journal of Gastroenterology 2008; 103(4): 914 doi: 10.1111/j.1572-0241.2007.01712.x
34
Sanjay Gupta, Satoshi Kobayashi, Sith Phongkitkarun, Lyle D. Broemeling, Zuxing Kan. Effect of Transcatheter Hepatic Arterial Embolization on Angiogenesis in an Animal ModelInvestigative Radiology 2006; 41(6): 516 doi: 10.1097/01.rli.0000209663.00629.8a
35
Jean-François Dufour. Targeted Therapies for Hepatocellular Carcinoma2011; : 74 doi: 10.2217/ebo.11.287
36
Jun-Ning Liu, Ji-Jiang Li, Shu Yan, Guang-Nian Zhang, Peng-Sheng Yi. Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysisFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1074793
37
A. Lam, D. Fernando, C.C. Sirlin, M. Nayyar, S.C. Goodwin, D.K. Imagawa, C. Lall. Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisationClinical Radiology 2017; 72(11): 994.e9 doi: 10.1016/j.crad.2017.07.003
38
Mary A. Maluccio, Anne M. Covey, Leah Ben Porat, Joanna Schubert, Lynn A. Brody, Constantinos T. Sofocleous, George I. Getrajdman, William Jarnagin, Ronald DeMatteo, Leslie H. Blumgart, Yuman Fong, Karen T. Brown. Transcatheter Arterial Embolization with Only Particles for the Treatment of Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2008; 19(6): 862 doi: 10.1016/j.jvir.2008.02.013
39
Jean-Marc Idée, Boris Guiu. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A reviewCritical Reviews in Oncology/Hematology 2013; 88(3): 530 doi: 10.1016/j.critrevonc.2013.07.003
40
Angelo Della Corte, Margherita Rimini, Stephanie Steidler, Diego Palumbo, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Francesco De Cobelli. Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New DevelopmentsCardioVascular and Interventional Radiology 2023; 46(2): 175 doi: 10.1007/s00270-022-03327-4
41
Zhen Fan Yang, Ronnie T.P. Poon, Yuqing Liu, Chi Keung Lau, David W. Ho, Ka Ho Tam, Chi Tat Lam, Sheung Tat Fan. High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesisMolecular Cancer Therapeutics 2006; 5(9): 2261 doi: 10.1158/1535-7163.MCT-06-0149
42
Bendaxin Cao, Ke Tian, Hejun Zhou, Chenjie Li, Deliang Liu, Yuyong Tan. Hepatic Arterioportal Fistulas: A Retrospective Analysis of 97 CasesJournal of Clinical and Translational Hepatology 2022; 10(4): 620 doi: 10.14218/JCTH.2021.00100
43
Min Xu, Majella MB Doyle, Babak Banan, Neeta Vachharajani, Xuanchuan Wang, Nael Saad, Kathryn Fowler, Elizabeth M. Brunt, Yiing Lin, William C. Chapman. Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver TransplantationJournal of the American College of Surgeons 2017; 225(1): 28 doi: 10.1016/j.jamcollsurg.2017.03.015